Literature DB >> 22359286

DNA methylation and histone modifications in breast cancer.

Ramona G Dumitrescu1.   

Abstract

Breast cancer is caused by progressive genetic alterations and epigenetic changes that trigger tumor development. Among the epigenetic alterations descried in breast cancer, DNA promoter methylation has been extensively studied and observed in genes involved in several critical signaling pathways that initiate and promote breast tumorigenesis. In addition to DNA hypermethylation, global methylation levels have been observed to decrease with breast cancer progression. In close connection with DNA methylation changes, histone modifications, especially the acetylation and methylation of histone lysines, play an essential role in the nucleosomes remodeling and gene expression regulation in breast cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22359286     DOI: 10.1007/978-1-61779-612-8_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  8 in total

1.  Oncofetal Epigenetic Bivalency in Breast Cancer Cells: H3K4 and H3K27 Tri-Methylation as a Biomarker for Phenotypic Plasticity.

Authors:  Terri L Messier; Joseph R Boyd; Jonathan A R Gordon; Janet L Stein; Jane B Lian; Gary S Stein
Journal:  J Cell Physiol       Date:  2016-03-10       Impact factor: 6.384

2.  Systematic nucleo-cytoplasmic trafficking of proteins following exposure of MCF7 breast cancer cells to estradiol.

Authors:  Gabriella Pinto; Abdulrab Ahmed M Alhaiek; Sepan Amadi; Amal T Qattan; Mark Crawford; Marko Radulovic; Jasminka Godovac-Zimmermann
Journal:  J Proteome Res       Date:  2014-01-24       Impact factor: 4.466

3.  Global DNA methylation and one-carbon metabolism gene polymorphisms and the risk of breast cancer in the Sister Study.

Authors:  Lisa A Deroo; Sophia C E Bolick; Zongli Xu; David M Umbach; David Shore; Clarice R Weinberg; Dale P Sandler; Jack A Taylor
Journal:  Carcinogenesis       Date:  2013-10-15       Impact factor: 4.944

4.  Oral Contraceptive Use May Modulate Global Genomic DNA Methylation and Promoter Methylation of APC1 and ESR1

Authors:  Mostafa Moradi Sarabi; Parvin Ghareghani; Fatemeh Khademi; Fatemeh Zal
Journal:  Asian Pac J Cancer Prev       Date:  2017-09-27

5.  Proximal and distal regulation of the HYAL1 gene cluster by the estrogen receptor α in breast cancer cells.

Authors:  Lydia Edjekouane; Samira Benhadjeba; Maïka Jangal; Hubert Fleury; Nicolas Gévry; Euridice Carmona; André Tremblay
Journal:  Oncotarget       Date:  2016-11-22

6.  Folic acid induces cell type-specific changes in the transcriptome of breast cancer cell lines: a proof-of-concept study.

Authors:  R Jordan Price; Karen A Lillycrop; Graham C Burdge
Journal:  J Nutr Sci       Date:  2016-04-26

7.  Mediator complex (MED) 7: a biomarker associated with good prognosis in invasive breast cancer, especially ER+ luminal subtypes.

Authors:  Chitra Joseph; Olivia Macnamara; Madeleine Craze; Roslin Russell; Elena Provenzano; Christopher C Nolan; Maria Diez-Rodriguez; Sultan N Sonbul; Mohammed A Aleskandarany; Andrew R Green; Emad A Rakha; Ian O Ellis; Abhik Mukherjee
Journal:  Br J Cancer       Date:  2018-03-28       Impact factor: 7.640

Review 8.  Perspectives on the Role of Histone Modification in Breast Cancer Progression and the Advanced Technological Tools to Study Epigenetic Determinants of Metastasis.

Authors:  Jialang Zhuang; Qin Huo; Fan Yang; Ni Xie
Journal:  Front Genet       Date:  2020-10-29       Impact factor: 4.599

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.